Please try another search
For the nine months ended 30 September 2019, The Medicines Company revenues decreased from $6.1M to $0K. Net loss before extraordinary items increased 2% to $193.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Interest Expense increase of 32% to $48M (expense), Other income decrease of 30% to $3.2M (income).
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | -0.7 |
Operating Income | -61.37 | -48 | -43.99 | -25.73 |
Net Income | -73.99 | -60.05 | -59.87 | -42.47 |
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Assets | 897.27 | 956.27 | 835.85 | 841.69 |
Total Liabilities | 923.27 | 918.14 | 911.24 | 863.95 |
Total Equity | -26 | 38.13 | -75.39 | -22.26 |
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 0 Months | 12 Months |
Cash From Operating Activities | -159.31 | -98.6 | -49.82 | -261.8 |
Cash From Investing Activities | 0.5 | 0.5 | 0.5 | 179.05 |
Cash From Financing Activities | 182.38 | 176.91 | 9.89 | 172.63 |
Net Change in Cash | 25.3 | 80.78 | -38.58 | 88.12 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review